Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS

Blood

Volumn 106, Issue 5, 2005, Pages 1864-1866

  Kemna, Erwin ^a   Pickkers, Peter ^b   Nemeth, Elizabeta ^b   Van Der Hoeven, Hans ^b   Swinkels, Dorine ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HEPCIDIN; HORMONE PRECURSOR; INTERLEUKIN 6; IRON; LIPOPOLYSACCHARIDE; PROHEPCIDIN; UNCLASSIFIED DRUG;

ADULT; ANEMIA; ARTICLE; CYTOKINE PRODUCTION; DISEASE MODEL; ENDOTOXEMIA; FEMALE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE URINE LEVEL; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON METABOLISM; MALE; NORMAL HUMAN; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 23944502314     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2005-03-1159     Document Type: Article

References (16)

1. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003;102:783-788.
2. Krause A, Neitz S, Magert HJ, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 2000;480:147-150.
3. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276:7806-7810.
4. Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001;276:7811-7819.
5. Weinstein DA, Roy CN, Fleming MD, et al. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood. 2002;100:3776-3781.
6. Nicolas G, Bennoun M, Porteu A, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A. 2002;99:4596-4601.
7. Roetto A, Papanikolaou G, Politou M, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet. 2003;33:21-22.
8. Nicolas G, Bennoun M, Devaux I, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A. 2001;98:8780-8785.
9. Nicolas G, Chauvet C, Viatte L, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002;110:1037-1044.
10. Nemeth E, Valore EV, Territo M, et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101:2461-2463.
11. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271-1276.
12. Prabhakar U, Eirikis E, Davis HM. Simultaneous quantification of proinflammatory cylokines in human plasma using the LabMAP assay. J Immunol Methods. 2002;260:207-218.
13. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090-2093.
14. Ashrafian H. Hepcidin: the missing link between hemochromatosis and infections. Infect Immun. 2003;71:6693-6700.
15. Johnson KJ, Chensue SW, Ward PA. Immunopathology. In: Rubin E, Farber JL, eds. Pathology. Philadelphia, PA: JB Lippincott; 1999:105-152.
16. Kulaksiz H, Gehrke SG, Janetzko A, et al. Prohepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut. 2004;53:735-743.